About Astraazin Pharmaceuticals
Astraazin Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing and medicinal product services in India. The company has 30 employees. Its Indian entity Astraazin Pharmaceuticals Private Limited reported revenue of βΉ4.00 Cr. Astraazin Pharmaceuticals offers products and services including Alexit-M and Hempack. Its focus areas include Contract Manufacturing, CRAMS Services, Outsourcing and Development and Pharmaceuticals.
Company details
Astraazin Pharmaceuticals was established in 2000 with core values such as integrity and excellence, starting from a small capital and a team of 10 employees. It has grown into a fast-expanding company offering a wide range of medicinal products globally, focusing on affordability and quality through contract manufacturing and research services. Operations are managed from locations in India, emphasizing innovation in fixed-dose combinations and accessibility of medicines, while contributing to societal and environmental concerns.
- Employees 30
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website astraazin.com
- Social LinkedIn X Instagram
- Legal Name Astraazin Pharmaceuticals Pvt. Ltd
- Date of Incorporation 08 Aug, 2014
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹4.00 Cr
FY 2025 · -6% YoY
- Indian entity net profit₹9.6 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹14.5 Lakh
FY 2025 · 4% margin
- Employee Count30
Associated legal entities of Astraazin Pharmaceuticals
Astraazin Pharmaceuticals operates through Astraazin Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Astraazin Pharmaceuticals Private Limited CIN U24239DL2014PTC270145 | Active | 08 Aug 2014 | New Delhi, Delhi | ₹4.0 Cr | 30 | 2 | View details |
Products & Services of Astraazin Pharmaceuticals
Astraazin Pharmaceuticals offers a comprehensive portfolio of products and services, including Alexit-M and Hempack.
A pharmaceutical product is manufactured for health-related applications.
Another pharmaceutical product is developed for specific medicinal uses.
Board of directors of Astraazin Pharmaceuticals Private Limited (Astraazin Pharmaceuticals)
Astraazin Pharmaceuticals Private Limited is the primary company behind Astraazin Pharmaceuticals. The board of Astraazin Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Seerat Riyaz, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Seerat Riyaz DIN 06825011 | Director | 08 Aug 2014 | 12 yrs 3 mo | Astraazin Pharmaceuticals Private Limited |
| Riyaz Ahmad Wani DIN 02508923 | Managing Director | 08 Aug 2014 | 12 yrs 3 mo | Astraazin Pharmaceuticals Private Limited |
Financials of Astraazin Pharmaceuticals
Figures of Astraazin Pharmaceuticals Private Limited, the primary company behind Astraazin Pharmaceuticals, for FY 2025. Revenue was ₹4.00 Cr (-6% year on year). Net profit was ₹9.6 Lakh (2% margin). EBITDA was ₹14.5 Lakh (4% margin). Revenue has grown at a compounded annual rate of +3% over three years and 0% over five years.
- ₹4.00 CrRevenue · FY 2025 · -6% YoY
- ₹9.6 LakhNet profit · 2% margin
- ₹14.5 LakhEBITDA · 4% margin
- ₹1 LakhPaid-up capital
- 30Employees (provident fund records)
- +3%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Astraazin Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Astraazin Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Astraazin Pharmaceuticals
Astraazin Pharmaceuticals has 30 employees.
The primary company behind Astraazin Pharmaceuticals, Astraazin Pharmaceuticals Private Limited, reported revenue of βΉ4.00 Cr for FY 2025, down 6% year on year.
Astraazin Pharmaceuticals was established in 2000 with core values such as integrity and excellence, starting from a small capital and a team of 10 employees. It has grown into a fast-expanding company offering a wide range of medicinal products globally, focusing on affordability and quality through contract manufacturing and research services. Operations are managed from locations in India, emphasizing innovation in fixed-dose combinations and accessibility of medicines, while contributing to societal and environmental concerns.
Astraazin Pharmaceuticals offers Alexit-M and Hempack.
Astraazin Pharmaceuticals operates through Astraazin Pharmaceuticals Private Limited.
The legal entities of Astraazin Pharmaceuticals currently have 2 directors, including Seerat Riyaz, Riyaz Ahmad Wani.
